Advertisement
Screener

Treace Medical Concepts, Inc. (TMCI) Increase (Decrease) in Inventories

2.8 / 5 stars · 68/120 Roast Me

Treace Medical Concepts, Inc. Increase (Decrease) in Inventories

Treace Medical Concepts, Inc. (TMCI) reported Increase (Decrease) in Inventories of $3.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-07

  • Treace Medical Concepts, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $3.18M, a 28.74% decline year-over-year.
  • Treace Medical Concepts, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $335.00K.
  • Treace Medical Concepts, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$5.39M.
  • Treace Medical Concepts, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$973.00K, a 141.72% decline year-over-year.
  • Treace Medical Concepts, Inc. increase (decrease) in inventories for fiscal 2025 was -$3.22M, a 132.21% decline from fiscal 2024.
  • Treace Medical Concepts, Inc. increase (decrease) in inventories for fiscal 2024 was $10.01M, a 1.65% increase from fiscal 2023.
  • Treace Medical Concepts, Inc. increase (decrease) in inventories for fiscal 2023 was $9.85M, a 12.30% increase from fiscal 2022.
  • Treace Medical Concepts, Inc. increase (decrease) in inventories for fiscal 2022 was $8.77M, a 219.92% increase from fiscal 2021.
Period endIncrease (Decrease) in Inventories 3 monthIncrease (Decrease) in Inventories 3 month as first filedIncrease (Decrease) in Inventories 6 monthIncrease (Decrease) in Inventories 9 monthIncrease (Decrease) in Inventories 12 monthIncrease (Decrease) in Inventories 12 month as first filed
2026-06-30$3.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$3.51M
10-Q · filed 2026-08-07
-$1.88M
derived: sum of 3 quarters · filed 2026-08-07
-$2.85M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$335.00K
10-Q · filed 2026-05-08
-$5.06M
derived: sum of 2 quarters · filed 2026-05-08
-$6.03M
derived: sum of 3 quarters · filed 2026-05-08
-$1.57M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31-$5.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$6.37M
derived: sum of 2 quarters · filed 2026-02-27
-$1.91M
derived: sum of 3 quarters · filed 2026-08-07
-$3.22M
10-K · filed 2026-02-27
2025-09-30-$973.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$3.48M
derived: sum of 2 quarters · filed 2026-08-07
$2.17M
10-Q · filed 2025-11-06
-$2.19M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$4.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
$3.14M
10-Q · filed 2026-08-07
-$1.21M
derived: sum of 3 quarters · filed 2026-08-07
$1.12M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$1.31M
10-Q · filed 2026-05-08
-$5.67M
derived: sum of 2 quarters · filed 2026-05-08
-$3.34M
derived: sum of 3 quarters · filed 2026-05-08
$2.08M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-$4.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$2.02M
derived: sum of 2 quarters · filed 2026-02-27
$3.40M
derived: sum of 3 quarters · filed 2026-02-27
$10.01M
10-K · filed 2026-02-27
2024-09-30$2.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$7.75M
derived: sum of 2 quarters · filed 2025-11-06
$14.37M
10-Q · filed 2025-11-06
$14.30M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$5.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$12.03M
10-Q · filed 2025-08-07
$11.97M
derived: sum of 3 quarters · filed 2026-02-27
$15.18M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$6.62M
10-Q · filed 2025-05-08
$6.55M
derived: sum of 2 quarters · filed 2026-02-27
$9.76M
derived: sum of 3 quarters · filed 2026-02-27
$13.27M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31-$67.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$3.14M
derived: sum of 2 quarters · filed 2026-02-27
$6.66M
derived: sum of 3 quarters · filed 2026-02-27
$9.85M
10-K · filed 2026-02-27
2023-09-30$3.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05
$6.73M
derived: sum of 2 quarters · filed 2024-11-05
$9.91M
10-Q · filed 2024-11-05
$12.66M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$3.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$6.70M
10-Q · filed 2024-08-06
$9.45M
derived: sum of 3 quarters · filed 2025-02-27
$13.06M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$3.19M
10-Q · filed 2024-05-07
$5.93M
derived: sum of 2 quarters · filed 2025-02-27
$9.55M
derived: sum of 3 quarters · filed 2025-02-27
$11.41M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$2.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$6.36M
derived: sum of 2 quarters · filed 2025-02-27
$8.22M
derived: sum of 3 quarters · filed 2025-02-27
$8.77M
10-K · filed 2025-02-27
2022-09-30$3.62M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$5.48M
derived: sum of 2 quarters · filed 2023-11-09
$6.03M
10-Q · filed 2023-11-09
$6.06M
derived: sum of 4 quarters · filed 2024-02-27
2022-06-30$1.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$2.41M
10-Q · filed 2023-08-09
$2.44M
derived: sum of 3 quarters · filed 2024-02-27
$5.24M
derived: sum of 4 quarters · filed 2024-02-27
2022-03-31$551.00K
10-Q · filed 2023-05-09
$548.00K
10-Q · filed 2022-05-06
$582.00K
derived: sum of 2 quarters · filed 2024-02-27
$3.38M
derived: sum of 3 quarters · filed 2024-02-27
$3.77M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31$31.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$2.83M
derived: sum of 2 quarters · filed 2024-02-27
$3.22M
derived: sum of 3 quarters · filed 2024-02-27
$2.74M
10-K · filed 2024-02-27
$3.09M
10-K · filed 2022-03-04
2021-09-30$2.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$3.19M
derived: sum of 2 quarters · filed 2022-11-09
$2.71M
10-Q · filed 2022-11-09
$228.00K
derived: sum of 4 quarters · filed 2023-03-08
2021-06-30$389.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
-$89.00K
10-Q · filed 2022-08-10
-$2.57M
derived: sum of 3 quarters · filed 2023-03-08
-$421.00K
derived: sum of 4 quarters · filed 2023-03-08
2021-03-31-$478.00K
10-Q · filed 2022-05-06
-$2.96M
derived: sum of 2 quarters · filed 2023-03-08
-$810.00K
derived: sum of 3 quarters · filed 2023-03-08
$420.00K
derived: sum of 4 quarters · filed 2023-03-08
2020-12-31-$2.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08
-$332.00K
derived: sum of 2 quarters · filed 2023-03-08
$898.00K
derived: sum of 3 quarters · filed 2023-03-08
$2.26M
10-K · filed 2023-03-08
$3.40M
10-K · filed 2022-03-04
2020-09-30$2.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$3.38M
derived: sum of 2 quarters · filed 2021-11-04
$4.74M
10-Q · filed 2021-11-04
2020-06-30$1.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$2.59M
10-Q · filed 2021-08-05
2020-03-31$1.36M
10-Q · filed 2021-05-25
2019-12-31$2.81M
10-K · filed 2022-03-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Mobia Medical, Inc. (MOBI)United States$0.293B
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Embecta Corp. (EMBC)United States$0.319B2.10
Cytosorbents Corp (CTSO)United States$0.274B-1.29
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39